Prostate Cancer - Results from #26120

Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study - Abstract April 2, 2012

Imaging diagnosis for prostate cancer biochemical recurrence after radical treatment - Abstract April 2, 2012

Treatment of the patient with castration-resistant biochemical progression of prostate cancer - Abstract April 2, 2012

Prostate Cancer Etiology April 2, 2012

Prostate Cancer Prognostic Nomograms April 2, 2012

A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 Update - Abstract April 2, 2012

Prostate bed motion during intensity-modulated radiotherapy treatment - Abstract April 2, 2012

Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: A population-based study - Abstract April 2, 2012

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer - Abstract April 2, 2012

Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate - Abstract April 2, 2012

Prostate Cancer Grading & Staging Systems April 1, 2012

Prostate Cancer Screening April 1, 2012

EAU 2012 - The key role of time in predicting post-radical prostatectomy urinary continence recovery rate: Conditional survival analysis - Session Highlights March 30, 2012

EAU 2012 - Dynamics of the pelvic floor in continent and stress urinary incontinent men after radical prostatectomy: A functional MRI study - Session Highlights March 30, 2012

EAU 2012 - Clinical prognosis and predictive factors of the further recovery of urinary continence in patients who do not achieve continence within 1 year after radical prostatectomy: 42 months follow-up - Session Highlights March 30, 2012

EAU 2012 - Introducing a nurse-led trans-perineal saturation prostate biopsy (TPSBx) service - Session Highlights March 30, 2012

Circulating tumor cells as a marker of response: Implications for determining treatment efficacy and evaluating new agents - Abstract March 30, 2012

Current status of immunological approaches for the treatment of prostate cancer - Abstract March 30, 2012

Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy - Abstract March 30, 2012

Predictive models for biochemical recurrence of prostate cancer after local treatment. Nomograms - Abstract March 30, 2012

Page 1307 of 1437